Pattern of Statins Use in Catalonia

Study Overview
=================
Brief Summary
-----------------
To describe the new statins prescription pattern in Catalonia (getting their first prescription for any statin, or receiving a change in their statin treatment including switching, changing in doses or adding ezetimibe/fibrates) since September 2009.

Detailed Description
-----------------
Pattern of statins use in Catalonia.

Official Title
-----------------
Pattern of Statins Use in Catalonia

Conditions
-----------------
Hypercholesteremia

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria Patient with a new prescription of statin Patients receiving one or more changes of the statins treatment Exclusion Criteria Patient with not full information

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Description of detailed clinical treatment in terms of duration of treatment, doses, drug switches and add-on therapy, in patients with hypercholesterolemia and on treatment with statins from the index date. |  | From 1st September 2009 to 30th August 2010 | 
| Type of prescriber | Number of patient, whom the drug was prescribed by the specified type of prescriber (specialist, general practitioner, etc.) | From 1st September 2009 to 30th August 2010 | 
| Date of change from previous statin to new. |  | From 1st September 2009 to 30th August 2010 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Description of demographic data including: Sex, Age, Height (cm), Weight (kg), Smoking habits (packs-years), Alcohol consume habits (units/week), active worker or retired, Pregnancy. |  | From 1st September 2009 to 30th August 2010 | 
| Total cholesterol | Total Cholesterol data was collected till the last laboratory values before the date of change from previous statin to new statin. That values will be collected for all the patients fulfilling criteria. | From 1st September 2009 to 30th August 2010 | 
| Low Density Lipoprotein (LDL) cholesterol concentration | LDL cholesterol data was collected till the last laboratory values before the date of change from previous statin to new statin. | From 1st September 2009 to 30th August 2010 | 
| High Density Lipoproteins (HDL) cholesterol concentration | HDL data was collected till the last laboratory values before the date of change from previous statin to new statin. | From 1st September 2009 to 30th August 2010 | 
| Triglicerides (TG) concentration | TG data was collected till the last laboratory values before the date of change from previous statin to new statin. | From 1st September 2009 to 30th August 2010 | 
| Aspartate Aminotransferase (ASAT) concentration | ASAT data was collected till the last laboratory values before the date of change from previous statin to new statin. | From 1st September 2009 to 30th August 2010 | 
| Serum Glucose concentration | Serum Glucose data was collected till the last laboratory values before the date of change from previous statin to new statin. | From 1st September 2009 to 30th August 2010 | 
| Serum Creatin Kinase (CK) concentration | CK data was collected till the last laboratory values before the date of change from previous statin to new statin. | From 1st September 2009 to 30th August 2010 | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Statins pattern of use, Hypercholesterolemic patients, Statins